OpenAI Misses Key Revenue and User Targets: High‑Risk Race Toward IPO
📊 MSFT — Piyasa Yorumu
▼ down · 65%The news indicates that Microsoft's close partner, OpenAI, has failed to meet its revenue and user targets. This could heighten concerns regarding the returns on Microsoft's artificial intelligence investments. Technically, the price is trading below the 20- and 50-day moving averages, and the MACD is below the signal line in negative territory. The RSI is at 44, indicating a weak zone, suggesting that selling pressure may continue in the short term. However, the 1.26% rise in the last 24 hours shows some recovery effort.
📊 NVDA — Piyasa Yorumu
▼ down · 65%The report indicates that OpenAI has failed to meet its revenue and user targets. This could heighten concerns regarding demand for NVDA's AI chips. Technical indicators also point to weakness: the RSI is near oversold territory at 36, the MACD is below zero and below its signal line, and the price is trading below both the 20-day and 50-day moving averages. Selling pressure is likely to persist in the short term.
📊 AMD — Piyasa Yorumu
▼ down · 60%OpenAI's failure to meet revenue and user targets could create a short-term negative sentiment in the AI sector. Since AMD relies on major customers like OpenAI for its AI chips, this news may pressure the stock. Technically, while the RSI is at 60 and the MACD is positive, the price trading near the 20-day moving average suggests limited upward momentum. The news could increase selling pressure in the short term, but a sharp decline is not expected.
📊 ASML — Piyasa Yorumu
▼ down · 60%OpenAI's failure to meet revenue and user targets could reduce short-term optimism in the artificial intelligence sector. As ASML is a critical supplier in AI chip production, this news may create pressure on the stock. Although technical indicators are neutral-to-positive (RSI 59, MACD positive), weakening momentum and the uncertainty generated by the news could increase selling pressure in the near term. Therefore, the stock is expected to show a slight decline within 1-3 days.